Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
LONDON — Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and rare blood types. Two patients in the U.K. received tiny doses — equivalent to a few teaspoons — of the…
